Brian Cahill - Jan 5, 2024 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
Chief Financial Officer
Signature
/s/ Brian Cahill
Stock symbol
EGRX
Transactions as of
Jan 5, 2024
Transactions value $
-$3,771
Form type
4
Date filed
1/9/2024, 05:01 PM
Previous filing
Dec 20, 2023
Next filing
Feb 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Tax liability -$3.77K -735 -1.55% $5.13 46.7K Jan 5, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The disposition reported on this Form 4 represents shares withheld by the Issuer to cover the tax liability upon the vesting of time-based restricted stock units previously granted and does not represent a discretionary transaction by the Reporting Person.